ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Patient Information Leaflet last updated on the eMC: 01/12/2011
PIL Ziagen 20 mg/ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 10/11/2011 and displayed until 01/12/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 05/04/2011 and displayed until 10/11/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 14/09/2010 and displayed until 05/04/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/06/2010 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 11/12/2009 and displayed until 24/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 19/06/2009 and displayed until 11/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 25/09/2008 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 17/06/2008 and displayed until 25/09/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to name of manufacturer
  • Change to Further Information section
Updated on 26/03/2007 and displayed until 17/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
Updated on 27/01/2005 and displayed until 26/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/07/2004 and displayed until 27/01/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 18/02/2004 and displayed until 08/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/05/2002 and displayed until 18/02/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   abacavir sulfate